JPH0330648A - Readily absorbable mineral-containing food and drink - Google Patents
Readily absorbable mineral-containing food and drinkInfo
- Publication number
- JPH0330648A JPH0330648A JP1166404A JP16640489A JPH0330648A JP H0330648 A JPH0330648 A JP H0330648A JP 1166404 A JP1166404 A JP 1166404A JP 16640489 A JP16640489 A JP 16640489A JP H0330648 A JPH0330648 A JP H0330648A
- Authority
- JP
- Japan
- Prior art keywords
- calcium
- mineral
- drink
- natto
- minerals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 38
- 239000011707 mineral Substances 0.000 title claims abstract description 37
- 235000013305 food Nutrition 0.000 title claims abstract description 23
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 29
- 229910052742 iron Inorganic materials 0.000 claims abstract description 10
- 229940124532 absorption promoter Drugs 0.000 claims abstract description 7
- 239000004220 glutamic acid Substances 0.000 claims abstract description 7
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 5
- 229910052802 copper Inorganic materials 0.000 claims abstract description 4
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 28
- 239000011575 calcium Substances 0.000 claims description 28
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 7
- 208000020084 Bone disease Diseases 0.000 abstract description 2
- 235000010755 mineral Nutrition 0.000 description 28
- 229960005069 calcium Drugs 0.000 description 27
- 235000013557 nattō Nutrition 0.000 description 21
- 229920000715 Mucilage Polymers 0.000 description 20
- 239000000853 adhesive Substances 0.000 description 20
- 229920002643 polyglutamic acid Polymers 0.000 description 15
- 108010020346 Polyglutamic Acid Proteins 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 210000000813 small intestine Anatomy 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- 239000005018 casein Substances 0.000 description 10
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 10
- 235000021240 caseins Nutrition 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 108010001441 Phosphopeptides Proteins 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000001132 Osteoporosis Diseases 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000005063 solubilization Methods 0.000 description 4
- 230000007928 solubilization Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000009056 active transport Effects 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000009057 passive transport Effects 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 235000020387 peach nectar Nutrition 0.000 description 2
- 235000013997 pineapple juice Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910001576 calcium mineral Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008085 high protein diet Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はミネラル吸収促進効果を有する飲食物に関する
。詳しくは、ミネラル及びミネラル吸収促進材としてポ
リ−α又はT−グルタミン酸を含有する飲食物に関し、
さらにはミネラル及びミネラル吸収促進材として納豆あ
るいは納豆菌由来の粘質物を含有する飲食物に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a food or drink that has the effect of promoting mineral absorption. Specifically, regarding minerals and foods and drinks containing poly-α or T-glutamic acid as a mineral absorption promoter,
Furthermore, the present invention relates to foods and drinks containing natto or mucilage derived from Bacillus natto as minerals and mineral absorption promoters.
生体を構成するミネラルには約20種類あるが、このう
ちカルシウム、鉄、亜鉛、銅、マグネシウムなどは日本
人にとって不足しがちで栄養学上問題視されている。特
にカネシウム、鉄は不足しがちである。There are about 20 types of minerals that make up the living body, but among these, Japanese people tend to be deficient in minerals such as calcium, iron, zinc, copper, and magnesium, which is considered a nutritional problem. In particular, we tend to be deficient in magnesium and iron.
カルシウムの場合、成人1日の所要量は600■とされ
ており、国民1人あたりの摂取量はやや下回っている程
度であるが、その吸収率の低さが原因となってカルシウ
ム不足が問題となっている。In the case of calcium, the daily requirement for an adult is said to be 600 kg, which is slightly below the intake per person, but calcium deficiency is a problem due to its low absorption rate. It becomes.
高齢者に高頻度に発症する骨粗N症はカルシウムの摂取
と排泄のバランスが乱れることが主たる要因であり、ね
たきり老人を増加させる主たる原因である。骨粗鬆症は
特に閉経後の女性に多く発症するが、女性ホルモン(ニ
ストロジエン)の分泌が著しく低下し小腸からのカルシ
ウムの吸収率が低下することも原因の一つと考えられて
いる。骨粗N症患者は年々増加しており、2000年に
は534万人になろうという。Osteoporosis N, which frequently occurs in the elderly, is mainly caused by an imbalance between calcium intake and excretion, and is the main cause of the increase in the number of bedridden elderly people. Osteoporosis occurs particularly often in postmenopausal women, and one of the causes is thought to be a marked decline in the secretion of female hormones (nistrodiene) and a decline in the absorption rate of calcium from the small intestine. The number of osteoporosis patients is increasing year by year, and it is estimated that there will be 5.34 million people by 2000.
一般にミネラルが吸収されるには可溶性の状態で小腸管
腔内に存在することが必要であるとされている。カルシ
ウムの場合、小腸上部でのビタミンDや各種ホルモンの
調節により制御されている、カルシウムが濃度勾配にさ
からって吸収される能動輸送の経路と小腸下部でのカル
シウムが濃度勾配に従って吸収される受動輸送の経路の
2通りがある。ところが圧倒的に小腸下部からの受動輸
送の割合が高く、能動輸送がカルシウム濃度が増加して
もある量販上は増加しないのに比べ、受動輸送は腸管内
の可溶性カルシウム濃度が増加すれば、それだけ輸送能
も高まる。It is generally believed that in order for minerals to be absorbed, they must be present in the lumen of the small intestine in a soluble state. In the case of calcium, there is an active transport pathway in which calcium is absorbed against the concentration gradient, which is controlled by the regulation of vitamin D and various hormones in the upper small intestine, and an active transport pathway in which calcium is absorbed in the lower small intestine according to the concentration gradient. There are two routes of passive transport. However, the proportion of passive transport from the lower part of the small intestine is overwhelmingly high, and while active transport does not increase in terms of mass sales even if the calcium concentration increases, passive transport increases as much as the soluble calcium concentration in the intestinal tract increases. Transport capacity will also increase.
小腸下部での可溶性カルシウム濃度および可溶性鉄濃度
を増加させることによりカルシウムおよび鉄の吸収促進
効果を示す素材に牛乳蛋白質のカゼインの分解物である
カゼインホスホペプチドがある。カゼインホスホペプチ
ドは含有するホスホセリンのリン酸基、酸性アミノ酸の
カルボキシル基によるキレート作用により、カルシウム
、鉄が可溶化状態に保たれ、小腸内の可溶性カルシウム
濃度、可溶性鉄濃度を増加させることにより吸収促進作
用をもつといわれているが、カゼインホスホペプチドを
生成するには酵素処理等の複雑な工程を経る必要があり
、しかも食品に添加した場合に、小腸に転送される過程
でさらに分解が進む可能性がある。カゼインをそのまま
食した場合にも、腸管内で分解されカゼインホスホペプ
チドが生成するため、ミネラルの吸収が促進される。し
かし、この場合にも腸管内で分解が進行し、ミネラル可
溶化能が消失する場合があり、またカゼインは溶解性が
悪いなどの欠点もある。Casein phosphopeptide, which is a decomposition product of the milk protein casein, is a material that exhibits the effect of promoting calcium and iron absorption by increasing the soluble calcium concentration and soluble iron concentration in the lower small intestine. Casein phosphopeptide maintains calcium and iron in a solubilized state due to the chelating action of the phosphate group of phosphoserine and the carboxyl group of acidic amino acids contained in it, and promotes absorption by increasing the concentration of soluble calcium and soluble iron in the small intestine. However, producing casein phosphopeptides requires complex processes such as enzymatic treatment, and furthermore, when added to food, it may be further degraded during the process of being transferred to the small intestine. There is sex. Even when casein is eaten as is, it is broken down in the intestinal tract to produce casein phosphopeptides, which promotes mineral absorption. However, in this case as well, decomposition progresses in the intestinal tract and the ability to solubilize minerals may be lost, and casein also has drawbacks such as poor solubility.
また、無機のミネラル塩とかミネラル粉末を食品に添加
する場合もあるが、他の共存する物質と不溶性の塩を作
る可能性が太き(ミネラルの生体内利用性はあまり改善
されない。ポリグルタミン酸(分子量14.000)が
in vitroの系においてカルシウムを可溶化する
ことはすでに知られていた(日本栄養食糧学会誌j1!
1(6) 433−439 (1986))が、ポリグ
ルタミン酸のin vitroO系におけるミネラル可
溶化がin vitroと同じ挙動を示すか否かは開示
されておらず又まったく予測すらできていなかった。Also, in some cases, inorganic mineral salts or mineral powders are added to foods, but there is a high possibility that they will form insoluble salts with other coexisting substances (the bioavailability of minerals will not be improved much. Polyglutamic acid ( It was already known that calcium (molecular weight 14.000) solubilizes calcium in an in vitro system (Japanese Journal of Nutrition and Food Science J1!
1(6) 433-439 (1986)) did not disclose whether or not mineral solubilization of polyglutamic acid in an in vitro O system exhibits the same behavior as in vitro, nor could it be predicted at all.
処理工程が簡便であり、溶解性良好で安全ではば広(食
品に利用でき得る成分を開発し、これを用いてミネラル
吸収促進効果をもつ飲食物を開発することである。The goal is to develop ingredients that have simple processing steps, good solubility, and are safe and widely usable in foods, and use these to develop foods and drinks that have the effect of promoting mineral absorption.
発明者らはミネラルを腸管内で可溶化状態に保つにはポ
リグルタミン酸が最も適しており、これを用いることに
より腸管を通してミネラルが体内吸収しやすくなること
を見出した結果、更に開発研究を行ないミネラルを体内
に補給し易い形の飲食物の開発に成功し、本発明を完成
させたものである。The inventors found that polyglutamic acid is the most suitable for keeping minerals in a solubilized state in the intestinal tract, and that by using polyglutamic acid, minerals can be easily absorbed into the body through the intestinal tract.As a result, they conducted further research and development to improve mineral The present invention has been completed by successfully developing a food and drink that can be easily replenished into the body.
すなわち本発明はミネラル及びミネラル吸収促進材とし
てポリ−α又はγ−グルタミン酸とを含有することを特
徴とする飲食物である。That is, the present invention is a food or drink characterized by containing a mineral and poly-α or γ-glutamic acid as a mineral absorption promoter.
本発明で用いるミネラルとしてカルシウム、鉄、マグネ
シウム、亜鉛、銅などの生体必須ミネラルの一部あるい
は全部が対象となる0本発明に用いるポリグルタミン酸
はα結合でもγ結合でもよく、また、純度が高いもので
もよいが、必ずしも純度が高い必要はなく、ポリグルタ
ミン酸を一構成成分とする納豆粘質物も利用できる。納
豆粘質物はポリーγ−グルタミン酸とレバンからなるが
、他の蛋白質、ペプチド、糖を含有していても本発明の
実施には何ら影響しない。The minerals used in the present invention include some or all of the essential minerals for living organisms such as calcium, iron, magnesium, zinc, and copper.The polyglutamic acid used in the present invention may be α-linked or γ-linked, and has high purity. However, it does not necessarily have to be highly pure, and natto mucilage containing polyglutamic acid as one of its constituents can also be used. Although the natto mucilage consists of poly-γ-glutamic acid and levan, it does not affect the practice of the present invention even if it contains other proteins, peptides, and sugars.
納豆粘質物の粘性を利用した食品加工物の例は今までに
あるが、納豆粘質物を用いることによりミネラル吸収促
進効果を有する飲食物を開発したものである。Although there have been examples of processed food products that utilize the viscosity of natto mucilage, we have developed a food and drink product that uses natto mucilage to promote mineral absorption.
飲食物としては、乳酸飲料、ジュース、清涼飲料などの
飲料形態、ゼリーなどのゲル状形態、菓子、ビスケット
、錠菓などの固型状形態、さらにふりかけなどの粉粒状
形態などのどの形態にも使用できる。・納豆粘質物の場
合、その調製段階で有臭成分が減縮ないしは完全に除か
れるので、臭いなどの使用上の制限要因はなく、どの割
合でも添加することができる。ポリグルタミン酸の場合
も添加割合の制限要因はない、しかし、一般に乾燥食品
には0.1〜10%程度、飲料の場合は0.01〜5%
程度、製品に添加すればよい。尚、同時にカルシウム、
鉄などのミネラルをあわせ添加するが、これらの添加量
は通常用いられる量でよい。Foods and drinks can be in any form, including beverages such as lactic acid drinks, juices, and soft drinks, gels such as jelly, solids such as sweets, biscuits, and tablets, and even powders such as furikake. Can be used. - In the case of natto mucilage, the odorous components are reduced or completely removed during the preparation stage, so there is no restriction on use such as odor, and it can be added in any proportion. In the case of polyglutamic acid, there is no limiting factor for the addition ratio, but it is generally around 0.1-10% for dry foods and 0.01-5% for drinks.
It can be added to the product to a certain degree. At the same time, calcium
Minerals such as iron are also added, but the amount of these additions may be the amount normally used.
本発明で用いるポリグルタミン酸はα−ポリグルタミン
酸でもγ−ポリグルタミン酸でもよく、納豆菌の分泌す
る粘質物あるいは納豆の粘質物よりそれらを単離して用
いてもよく、また粘質物をそのまま用いても何ら支障は
ない。The polyglutamic acid used in the present invention may be α-polyglutamic acid or γ-polyglutamic acid, and it may be used after being isolated from the mucilage secreted by Bacillus natto or the mucilage of natto, or the mucilage may be used as it is. There are no problems.
実施例
く納豆粘質物の調製例〉
市販の納豆1kgを3倍世の水で洗浄した後、が布によ
り豆の部分を除去した。粘稠な炉液を遠心分離し、その
上清をエタノールに最終濃度が85%エタノールとなる
よう徐々に滴加し、沈殿する精魂を集め、蒸留水に溶解
した。さらにエタノールに滴加する操作を繰り返した後
、沈殿した精魂を蒸留水に溶解し、凍結乾燥して乾燥粉
末13gを得た。この納豆粘質物の蛋白含量は54%、
糖含量は44%、蛋白質のうち70%がグルタミン酸で
あった。Example Preparation of Natto Mucilage Product> After washing 1 kg of commercially available natto with 3 times the amount of water, the bean part was removed with a cloth. The viscous furnace solution was centrifuged, and the supernatant was gradually added dropwise to ethanol to give a final concentration of 85% ethanol, and the precipitated spirits were collected and dissolved in distilled water. After repeating the operation of adding dropwise to ethanol, the precipitated spirit was dissolved in distilled water and freeze-dried to obtain 13 g of dry powder. The protein content of this natto mucilage is 54%.
The sugar content was 44%, and 70% of the protein was glutamic acid.
実施例1 〈カルシウム可溶化試験〉 この納豆粘質物を用いて以下の実験をおこなった。Example 1 <Calcium solubilization test> The following experiment was conducted using this natto mucilage.
納豆粘質物溶液(1mg/+nj2)の0.5n+42
と10mM塩化カルシウム溶液0.5n/!を予め混合
し、その後pH7、pH8の20mMリン酸緩衝液1、
0 m lを加え、37°Cで2時間インキュベーショ
ンした後遠心分離した。生じたリン酸カルシウムの沈殿
を除去し、上清のカルシウム濃度を原子吸光法により測
定し、残存しているカルシウムを可溶性カルシウムとし
て残存率を求めた。比較対照として納豆粘質物溶液の代
りに蒸留水を用い同一試験をおこなった。その結果を表
1に示す。0.5n+42 of natto mucilage solution (1mg/+nj2)
and 10mM calcium chloride solution 0.5n/! pre-mix and then add 20mM phosphate buffer 1, pH 7, pH 8,
0 ml was added, incubated at 37°C for 2 hours, and then centrifuged. The resulting calcium phosphate precipitate was removed, and the calcium concentration of the supernatant was measured by atomic absorption spectrometry, and the remaining calcium was determined as soluble calcium to determine the residual rate. As a comparison, the same test was conducted using distilled water instead of the natto mucilage solution. The results are shown in Table 1.
実施例2
く動物試験例〉
ラット(Sprague−Dawley系雄性4週令各
群n=8)を10日間明朗の8時間(9:00〜17:
00)ミールフィーディングした後、所要量のカルシウ
ムを含む試験食を1.5時間項食させ、更に1時間後に
ジエチルエーテル麻酔下にて開腹し、小腸上部(前半部
)および下部(後半部)の内容物を生理的食塩水(0,
9%Nal、l)に懸濁採取した。Example 2 Animal test example> Rats (Sprague-Dawley male, 4 weeks old, n = 8 in each group) were subjected to 8 hours of light light (9:00-17:00) for 10 days.
00) After meal feeding, a test meal containing the required amount of calcium was fed for 1.5 hours, and after another 1 hour, the abdomen was opened under anesthesia with diethyl ether and the upper (first half) and lower (second half) small intestine were examined. The contents of the saline solution (0,
The suspension was collected in 9% Nal, 1).
生理的食塩水は定容後、遠心分離し、可溶性および不溶
性画分に分け、それぞれのカルシウム量を原子吸光法に
より測定した。ラットには試験食として20%納豆粘質
物食、20%分離大豆蛋白質食、20%納豆凍結乾燥物
食、20%粘質物除去納豆凍結乾燥物食、20%カゼイ
ン食を与えた。After the physiological saline solution had been fixed in volume, it was centrifuged and separated into soluble and insoluble fractions, and the amount of calcium in each fraction was measured by atomic absorption spectrometry. The rats were given 20% natto mucilage diet, 20% isolated soybean protein diet, 20% natto freeze-dried diet, 20% mucilage-free natto freeze-dried diet, and 20% casein diet as test foods.
結果は表2に可溶性カルシウムと不溶性カルシウムの割
合を示した。The results are shown in Table 2, which shows the ratio of soluble calcium to insoluble calcium.
以上の結果より納豆粘質物には小腸内の可溶性カルシウ
ムを増大させる作用があり、それによりカルシウムの吸
収を促進する作用があることが明らかになった。またそ
の可溶化の程度はカゼインと同等であり、カゼインの酵
素分解物であるカゼインホスホペプチドと同等の効果を
持つことが明らかになった。The above results revealed that natto mucilage has the effect of increasing soluble calcium in the small intestine, thereby promoting calcium absorption. It was also revealed that the degree of solubilization is the same as that of casein, and that it has the same effect as casein phosphopeptide, which is an enzymatic decomposition product of casein.
カルシウム以外のミネラルについても納豆粘質物はやは
り同様の小腸内可溶化促進作用をもち、小腸におけるそ
の吸収を促進する。Regarding minerals other than calcium, natto mucilage also has a similar effect of promoting solubilization in the small intestine, and promotes their absorption in the small intestine.
実施例3
〈飲食品への適用例〉
次に実施例2で調製した納豆粘質物および納豆菌を培養
して得たポリグルタミン酸を添加した飲食物について示
す。Example 3 <Example of application to food and drink> Next, food and drink to which the natto mucilage prepared in Example 2 and polyglutamic acid obtained by culturing Bacillus natto are added will be described.
3−1 パイナツプルジュース
パイナツプル濃縮果汁8.3g、果糖ぶどう糖液1!!
18.5g、庶’fJfI 液F! 4.6 g、クエ
ン酸0.24g、ビタミンC0,04g、ポリグルタミ
ン酸1.0g。3-1 Pineapple juice pineapple concentrated fruit juice 8.3g, fructose glucose solution 1! !
18.5g, 庶'fJfI Liquid F! 4.6 g, citric acid 0.24 g, vitamin C 0.04 g, polyglutamic acid 1.0 g.
炭酸カルシウム3.8gに水を8.3g加え混合し、香
料を0.22 g添加してシラツブを作った。このシラ
ツブに4倍量の水を添加し、ストレーニングしおりを除
いた後加熱殺菌して冷却しパイナツプルジュースを調製
した。8.3 g of water was added to 3.8 g of calcium carbonate and mixed, and 0.22 g of flavoring agent was added to make a syrup. Four times the amount of water was added to this syllabary, and after removing the straining bookmarks, it was heat sterilized and cooled to prepare pineapple juice.
3−2 クツキー
小麦粉200g、砂糖120g、バター100g、全卵
40g1ポリグルタミン酸15g、炭酸カルシウム20
g1ベイキングパウダー3g1バニラエツセンス1g、
食塩1gを用いて生地を生成し、冷却した後、整型して
焙焼しクツキーを調製した。3-2 200g of Kutsky flour, 120g of sugar, 100g of butter, 40g of whole eggs, 15g of polyglutamic acid, 20g of calcium carbonate
g1 baking powder 3g1 vanilla essence 1g,
A dough was prepared using 1 g of common salt, cooled, shaped and roasted to prepare kutsky.
3−3 羊かん
寒天2.6gを浸漬し充分吸水した後、水洗脱水し、細
かくちぎって鍋に入れ水72ml加えて加熱混合し、寒
天を完全に溶解させた。さらに砂糖180g、ポリグル
タミン酸6g、炭酸カルシウム10gを加えて加熱し沸
騰させ、篩でこした後が液を再び沸騰させ、生あんを1
10g加えて練り上げた。温かいうちに缶などの型枠に
流しこんで放冷し、凝固させ羊かんを調製した。3-3 After soaking 2.6 g of Yokan agar and absorbing enough water, it was washed with water, dehydrated, broken into small pieces, placed in a pot, added with 72 ml of water, and mixed with heat to completely dissolve the agar. Furthermore, add 180 g of sugar, 6 g of polyglutamic acid, and 10 g of calcium carbonate, heat to boil, strain through a sieve, bring the liquid to a boil again, and add 1
10g was added and kneaded. Yokan was prepared by pouring the mixture into molds such as cans while still warm and allowing it to cool and solidify.
3−4 レモンジュース
レモン濃縮果汁2.1g、果糖ぶどう糖液糖10、 O
gとクエン酸0.16g、ビタミンC0,04g、ポリ
グルタミン酸2.0g、クエン酸鉄0.6gを水で溶解
したものと、ナリンジン0.03 gを加熱した水に溶
解したものとを混合し、香料を0.2g加えた。全量は
200gとなるようにした。その後ストレーニングし、
更に加熱殺菌し、レモンジュースを調製した。3-4 Lemon juice Lemon concentrated juice 2.1g, fructose glucose liquid sugar 10, O
g, 0.16 g of citric acid, 0.04 g of vitamin C, 2.0 g of polyglutamic acid, 0.6 g of iron citrate dissolved in water, and 0.03 g of naringin dissolved in heated water were mixed. , 0.2 g of fragrance was added. The total amount was set to 200g. Then strain,
Furthermore, it was heat sterilized to prepare lemon juice.
3−5 ピーチネクター
ビーチピユーレ120.0g、果糖ぶどう糖液糖26.
6g、グラニュー糖19.4g、クエン酸0.24g1
リンゴ酸0.32g、ビタミンC0,12g、納豆粘質
物2.0g、乳酸カルシウム15.4 gと水216、
0 gを混合し、デアレータ−で脱気した後、ホモゲナ
イズし、加熱殺菌した。その後冷却してピーチネクター
を調製した。3-5 Peach nectar beach puree 120.0g, high fructose glucose liquid sugar 26.
6g, granulated sugar 19.4g, citric acid 0.24g1
0.32 g of malic acid, 0.12 g of vitamin C, 2.0 g of natto mucilage, 15.4 g of calcium lactate, and 216 g of water.
0 g were mixed, degassed using a dealerator, homogenized, and heat sterilized. Thereafter, it was cooled to prepare peach nectar.
3−6 キャラメル
砂P’220g、水あめ485gを少量の水に煮とかし
、冷却した後、牛乳80n+jl!、練乳130m2、
小麦粉40g、納豆粘質物15g、乳酸カルシウム50
gを徐々に加え、50°C〜60°Cに加熱しながら混
合した。混合後さらに煮つめた後、バター40gと香料
1gを混合し、容器に流しこみ放冷した。その後適当な
大きさに切り、キャラメルを調製した。3-6 Boil 220g of caramel sand P' and 485g of starch syrup in a small amount of water, cool it, and add 80n+jl of milk! , condensed milk 130m2,
40g of wheat flour, 15g of natto mucilage, 50g of calcium lactate
g was gradually added and mixed while heating to 50°C to 60°C. After mixing and further boiling, 40 g of butter and 1 g of fragrance were mixed, poured into a container, and left to cool. Thereafter, it was cut into appropriate sizes and caramel was prepared.
本発明はミネラル及びミネラル吸収促進材を含有するこ
とを特徴とする飲食物に関し、これを食することにより
腸管内に可溶性のミネラルの濃度が増加することによっ
てミネラルの吸収が促進され、成長期の児童のミネラル
の補強、老年期の骨粗■症に代表される骨疾患の予防、
さらに健康人においても高タンパク食などによっておこ
るミネラルのアンバランスの防止などの効果が期待でき
る。The present invention relates to foods and drinks that are characterized by containing minerals and mineral absorption promoters.Eating these foods increases the concentration of soluble minerals in the intestinal tract, thereby promoting mineral absorption. Mineral reinforcement for children, prevention of bone diseases such as osteoporosis in old age,
Furthermore, even in healthy people, it can be expected to have effects such as preventing mineral imbalance caused by high-protein diets.
Claims (1)
はγ−グルタミン酸を含有することを特徴とする飲食物 2)ミネラルとしてカルシウム、鉄、マグネシウム、亜
鉛、銅などの生体必須ミネラルの一部あるいは全部を含
有することを特徴とする特許請求項第1項記載の飲食物[Scope of Claims] 1) Foods and beverages characterized by containing poly-α or γ-glutamic acid as minerals and mineral absorption promoters 2) Minerals that are essential to living organisms such as calcium, iron, magnesium, zinc, and copper The food and drink according to claim 1, characterized in that it contains part or all of
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1166404A JP2712583B2 (en) | 1989-06-28 | 1989-06-28 | Foods and drinks containing easily absorbable minerals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1166404A JP2712583B2 (en) | 1989-06-28 | 1989-06-28 | Foods and drinks containing easily absorbable minerals |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0330648A true JPH0330648A (en) | 1991-02-08 |
JP2712583B2 JP2712583B2 (en) | 1998-02-16 |
Family
ID=15830793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1166404A Expired - Lifetime JP2712583B2 (en) | 1989-06-28 | 1989-06-28 | Foods and drinks containing easily absorbable minerals |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2712583B2 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0605757A1 (en) * | 1992-11-25 | 1994-07-13 | Ajinomoto Co., Inc. | Compositions and goods containing minerals and poly-gamma-glutamic acid |
FR2704393A1 (en) * | 1993-04-30 | 1994-11-04 | Boiron | Nutritional supplement which can be taken orally to optimise growth and maintain robustness of bones |
JPH07127057A (en) * | 1993-11-02 | 1995-05-16 | Kajima Corp | Compression system permanent anchor |
EP0826310A1 (en) * | 1995-05-12 | 1998-03-04 | Ajinomoto Co., Inc. | FEED COMPOSITION CONTAINING POLY-$g(g)-GLUTAMIC ACID |
EP0838160A1 (en) * | 1996-10-25 | 1998-04-29 | Ajinomoto Co., Ltd. | The use of poly-gamma-glutamic acid for preparing an agent for increasing the phosphorus assimilation |
JP2006316022A (en) * | 2005-05-16 | 2006-11-24 | Tung Hai Biotechnology Corp | gamma-POLYGLUTAMIC ACID (gamma-PGA, H FORM) AND gamma-POLYGLUTAMATE USED AS NUTRITION SUPPLEMENT IN DIETARY PRODUCT |
WO2007135801A1 (en) | 2006-05-23 | 2007-11-29 | Toyo Boseki Kabushiki Kaisha | MICROORGANISM CAPABLE OF PRODUCING γ-L-PGA, METHOD FOR PRODUCTION OF γ-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN |
JP2011037842A (en) * | 2009-07-16 | 2011-02-24 | Kao Corp | Inhibitor for blood gip level elevation |
JP2011037843A (en) * | 2009-07-16 | 2011-02-24 | Kao Corp | Agent for inhibiting increase in postprandial blood insulin level |
US9056066B2 (en) | 2011-01-12 | 2015-06-16 | Kao Corporation | Agent for suppressing elevation of blood GIP level, agent for suppressing elevation of blood insulin level, agent for lowering blood triglyceride level after meal ingestion, and agent for suppressing elevation of blood glucose level |
JP2017201898A (en) * | 2016-05-09 | 2017-11-16 | ポッカサッポロフード&ビバレッジ株式会社 | Beverage |
JP2019534046A (en) * | 2016-11-01 | 2019-11-28 | ジロニックス・アイピー・ホールディングス・ピーティーイー.リミテッド | Gamma-polyglutamic acid and zinc composition |
US11944640B2 (en) | 2016-11-01 | 2024-04-02 | Xylonix PTE. LTD. | Zinc-[gamma]-PGA compositions and methods for treating cancer |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6437251A (en) * | 1987-08-03 | 1989-02-07 | Takeda Chemical Industries Ltd | Beverage and method for improving quality thereof |
JPS6437260A (en) * | 1987-08-04 | 1989-02-07 | Takeda Chemical Industries Ltd | Cereal grain food and method for improving quality thereof |
JPH01132355A (en) * | 1987-03-24 | 1989-05-24 | Takeda Chem Ind Ltd | Egg food and method for improving quality of said food |
JPH01132347A (en) * | 1987-03-24 | 1989-05-24 | Takeda Chem Ind Ltd | Polyglutamic acid-containing noodles and shape retaining agent |
JPH01132331A (en) * | 1987-03-24 | 1989-05-24 | Takeda Chem Ind Ltd | Polyglutamic acid-containing bakery food and shape retaining agent |
JPH01165353A (en) * | 1987-12-18 | 1989-06-29 | Takeda Chem Ind Ltd | Tofu product and quality improvement thereof |
-
1989
- 1989-06-28 JP JP1166404A patent/JP2712583B2/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01132355A (en) * | 1987-03-24 | 1989-05-24 | Takeda Chem Ind Ltd | Egg food and method for improving quality of said food |
JPH01132347A (en) * | 1987-03-24 | 1989-05-24 | Takeda Chem Ind Ltd | Polyglutamic acid-containing noodles and shape retaining agent |
JPH01132331A (en) * | 1987-03-24 | 1989-05-24 | Takeda Chem Ind Ltd | Polyglutamic acid-containing bakery food and shape retaining agent |
JPS6437251A (en) * | 1987-08-03 | 1989-02-07 | Takeda Chemical Industries Ltd | Beverage and method for improving quality thereof |
JPS6437260A (en) * | 1987-08-04 | 1989-02-07 | Takeda Chemical Industries Ltd | Cereal grain food and method for improving quality thereof |
JPH01165353A (en) * | 1987-12-18 | 1989-06-29 | Takeda Chem Ind Ltd | Tofu product and quality improvement thereof |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0605757A1 (en) * | 1992-11-25 | 1994-07-13 | Ajinomoto Co., Inc. | Compositions and goods containing minerals and poly-gamma-glutamic acid |
EP0605757B1 (en) * | 1992-11-25 | 2001-08-16 | Ajinomoto Co., Inc. | Compositions and goods containing minerals and poly-gamma-glutamic acid |
FR2704393A1 (en) * | 1993-04-30 | 1994-11-04 | Boiron | Nutritional supplement which can be taken orally to optimise growth and maintain robustness of bones |
JPH07127057A (en) * | 1993-11-02 | 1995-05-16 | Kajima Corp | Compression system permanent anchor |
EP0826310A1 (en) * | 1995-05-12 | 1998-03-04 | Ajinomoto Co., Inc. | FEED COMPOSITION CONTAINING POLY-$g(g)-GLUTAMIC ACID |
EP0826310A4 (en) * | 1995-05-12 | 1998-05-27 | Ajinomoto Kk | FEED COMPOSITION CONTAINING POLY--g(g)-GLUTAMIC ACID |
EP0838160A1 (en) * | 1996-10-25 | 1998-04-29 | Ajinomoto Co., Ltd. | The use of poly-gamma-glutamic acid for preparing an agent for increasing the phosphorus assimilation |
JP2006316022A (en) * | 2005-05-16 | 2006-11-24 | Tung Hai Biotechnology Corp | gamma-POLYGLUTAMIC ACID (gamma-PGA, H FORM) AND gamma-POLYGLUTAMATE USED AS NUTRITION SUPPLEMENT IN DIETARY PRODUCT |
WO2007135801A1 (en) | 2006-05-23 | 2007-11-29 | Toyo Boseki Kabushiki Kaisha | MICROORGANISM CAPABLE OF PRODUCING γ-L-PGA, METHOD FOR PRODUCTION OF γ-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN |
JP2011037842A (en) * | 2009-07-16 | 2011-02-24 | Kao Corp | Inhibitor for blood gip level elevation |
JP2011037843A (en) * | 2009-07-16 | 2011-02-24 | Kao Corp | Agent for inhibiting increase in postprandial blood insulin level |
US8853153B2 (en) | 2009-07-16 | 2014-10-07 | Kao Corporation | Agent for suppressing elevation of blood GIP concentration |
US8933025B2 (en) | 2009-07-16 | 2015-01-13 | Kao Corporation | Agent for suppressing postprandial elevation of blood insulin concentration |
US9056066B2 (en) | 2011-01-12 | 2015-06-16 | Kao Corporation | Agent for suppressing elevation of blood GIP level, agent for suppressing elevation of blood insulin level, agent for lowering blood triglyceride level after meal ingestion, and agent for suppressing elevation of blood glucose level |
JP2017201898A (en) * | 2016-05-09 | 2017-11-16 | ポッカサッポロフード&ビバレッジ株式会社 | Beverage |
JP2019534046A (en) * | 2016-11-01 | 2019-11-28 | ジロニックス・アイピー・ホールディングス・ピーティーイー.リミテッド | Gamma-polyglutamic acid and zinc composition |
US11944640B2 (en) | 2016-11-01 | 2024-04-02 | Xylonix PTE. LTD. | Zinc-[gamma]-PGA compositions and methods for treating cancer |
Also Published As
Publication number | Publication date |
---|---|
JP2712583B2 (en) | 1998-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2289955C2 (en) | Nutritional formula for prophylaxis and treatment of immune conditions | |
JPH0330648A (en) | Readily absorbable mineral-containing food and drink | |
JPH07242539A (en) | Composition having laxative effect | |
JPH07252156A (en) | Medicine for prevention and therapy of osteoporosis | |
JP3693359B2 (en) | Bone strengthening promoter | |
JP2002523025A (en) | Composition | |
JP3232718B2 (en) | Easy-absorbable mineral-containing composition and food and drink containing it | |
JPH0272843A (en) | Mineral supplement containing sugar alcohol | |
CN108025032A (en) | Muscle synthesis accelerant | |
JPH0648955A (en) | Activator for digestive tract cell | |
JPH07222571A (en) | Food/beverage for athlete | |
JP5281895B2 (en) | Calcium absorption promoter | |
JPH0621077B2 (en) | Hematopoietic agent | |
JP3552075B2 (en) | Easily absorbable calcium composition | |
JP3551149B2 (en) | Easy-absorbable mineral-containing composition and food and drink containing it | |
CN108902324A (en) | A kind of person in middle and old age's high-calcium milk powder and preparation method thereof | |
JP2016506753A (en) | Food composition and use thereof | |
JP2900070B2 (en) | Potassium supplement composition for food and method for producing the same | |
EP1429629A1 (en) | Compositions for appetite control and related methods | |
AU2002325007A1 (en) | Compositions for appetite control and related methods | |
JPH0995448A (en) | Increase in biotin concentration in blood and biotin-containing beverage or food product | |
KR101322282B1 (en) | Composition for bone growth promotion comprising Gelatin hydrolysates | |
JP2964290B2 (en) | Mineral absorption enhancer | |
JPH11504201A (en) | Dairy products fortified with crushed eggshell | |
JP4852681B2 (en) | Intestinal cytolytic activity inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091031 Year of fee payment: 12 |